Evidence map›Paper›PMID 39737353›Full record

ArticleIranian journal of microbiology2024

Lessons from an 11-year retrospective cohort study of

Pegah Shakib, Mohsen Arzanlou, Pouria Sobhi, Mehdi Mojebi, Mohammad Bahrami, Faraz Mahdizadeh, Leyla Asadi, Masoud Amanzadeh, Alireza Mohammadnia, Farzad Khademi and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Iranian journal of microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Pegah ShakibRazi Herbal Medicines Research Center, Department of Microbiology, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.
Mohsen ArzanlouDepartment of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Pouria SobhiStudent Research Committee, Ardabil University of Medical Sciences, Ardabil, Iran.
Mehdi MojebiStudent Research Committee, Ardabil University of Medical Sciences, Ardabil, Iran.
Mohammad BahramiStudent Research Committee, Ardabil University of Medical Sciences, Ardabil, Iran.
Faraz MahdizadehStudent Research Committee, Ardabil University of Medical Sciences, Ardabil, Iran.
Leyla AsadiImam Hospital Laboratory, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Masoud AmanzadehDepartment of Health Information Management, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Alireza MohammadniaDepartment of Health Information Management, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Farzad KhademiDepartment of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Rashid RamazanzadehDepartment of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: The global problem of urinary tract infections (UTIs) caused by antibiotic-resistant bacteria is due to limited treatment options. This study aimed to examine the prevalence, etiology, and management implications of Materials and Methods: 2340 samples of retrospective data on Results: It was found that the lowest level of resistance was related to nitrofurantoin, followed by imipenem. In 2018, the number of Conclusion: Significant correlations were identified between specific hospital wards and resistance to antibiotics. These findings underscore the need for continuous surveillance and tailored antibiotic stewardship programs to combat the rising trend of antibiotic resistance.

Indexed as

Cohort studiesEscherichia coli (E. coli)IranMultidrug-resistance (MDR)Retrospective studiesUrinary tract infection (UTI)

Identifiers

PMID39737353
PMCPMC11682551

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.